News

Featured News

  • 2019 |
  • 2018 |
  • 2017 |
  • News | April 9, 2019

    Pliant Therapeutics Reports Positive Results Of Phase 1 Clinical Study

    Read More

    News | March 1, 2019

    Genome editing company Precision proposes $100M IPO

    Read More

    News | January 16, 2019

    Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

    Read More

    Press Release | January 4, 2019

    Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

    Read More